Everett Harris & CO Novo Nordisk A S Transaction History

Everett Harris & CO

$7.5 Billion
Q1 2024

A detailed history of Everett Harris & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Everett Harris & CO holds 6,497,372 shares of NVO stock, worth $879 Million. This represents 11.12% of its overall portfolio holdings.

Number of Shares

6,497,372

Previous 6,512,789 0.24%

Holding current value

$879 Million

Previous $674 Million 23.82%

% of portfolio

11.12%

Previous 9.7%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$102.11 - $135.92 $1.57 Million - $2.1 Million	-15,417 Reduced 0.24%	6,497,372 $834 Million
Q4 2023 Jan 18, 2024	SELL	$87.78 - $105.45 $2.32 Million - $2.79 Million	-26,413 Reduced 0.4%	6,512,789 $674 Million
Q3 2023 Oct 23, 2023	BUY	$90.94 - $199.54 $295 Million - $648 Million	3,246,806 Added 98.62%	6,539,202 $595 Million
Q2 2023 Jul 26, 2023	SELL	$155.98 - $172.65 $3.02 Million - $3.34 Million	-19,370 Reduced 0.58%	3,292,396 $533 Million
Q1 2023 Apr 24, 2023	SELL	$132.34 - $159.14 $998,240 - $1.2 Million	-7,543 Reduced 0.23%	3,311,766 $527 Million

Q4 2022 Jan 20, 2023	BUY	$102.55 - $135.33 $330,108 - $435,627	3,219 Added 0.1%	3,319,309 $0
Q3 2022 Oct 21, 2022	BUY	$95.28 - $116.93 $5.18 Million - $6.36 Million	54,370 Added 1.67%	3,316,090 $330 Million
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $1.13 Million - $1.33 Million	-10,943 Reduced 0.33%	3,261,720 $363 Million
Q1 2022 Apr 22, 2022	BUY	$93.1 - $112.54 $576,754 - $697,185	6,195 Added 0.19%	3,272,663 $363 Million
Q4 2021 Feb 02, 2022	SELL	$95.88 - $117.08 $480,838 - $587,156	-5,015 Reduced 0.15%	3,266,468 $366 Million
Q3 2021 Nov 03, 2021	SELL	$84.42 - $106.62 $244,986 - $309,411	-2,902 Reduced 0.09%	3,271,483 $314 Million
Q2 2021 Jul 29, 2021	BUY	$67.66 - $84.76 $970,312 - $1.22 Million	14,341 Added 0.44%	3,274,385 $274 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $2.54 Million - $2.87 Million	37,873 Added 1.18%	3,260,044 $220 Million
Q4 2020 Feb 04, 2021	BUY	$63.89 - $73.8 $1.15 Million - $1.32 Million	17,946 Added 0.56%	3,222,171 $225 Million
Q3 2020 Nov 03, 2020	BUY	$63.69 - $70.22 $722,563 - $796,645	11,345 Added 0.36%	3,204,225 $222 Million
Q2 2020 Jul 29, 2020	BUY	$58.54 - $67.94 $2.18 Million - $2.53 Million	37,168 Added 1.18%	3,192,880 $209 Million
Q1 2020 Apr 29, 2020	BUY	$49.46 - $64.78 $1.77 Million - $2.31 Million	35,695 Added 1.14%	3,155,712 $190 Million
Q4 2019 Jan 27, 2020	SELL	$49.86 - $58.26 $45,173 - $52,783	-906 Reduced 0.03%	3,120,017 $181 Million
Q3 2019 Nov 06, 2019	BUY	$47.54 - $53.43 $188,971 - $212,384	3,975 Added 0.13%	3,120,923 $161 Million
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $65,973 - $73,982	1,410 Added 0.05%	3,116,948 $159 Million
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $302,962 - $343,937	6,535 Added 0.21%	3,115,538 $163 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $858,424 - $976,421	20,665 Added 0.67%	3,109,003 $143 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $734,132 - $804,468	-15,700 Reduced 0.51%	3,088,338 $146 Million
Q2 2018 Jul 27, 2018	BUY	$44.29 - $50.42 $172,952 - $196,890	3,905 Added 0.13%	3,104,038 $143 Million
Q1 2018 Apr 20, 2018	BUY	$48.49 - $58.14 $532,177 - $638,086	10,975 Added 0.36%	3,100,133 $153 Million
Q4 2017 Feb 01, 2018	SELL	$47.53 - $53.73 $537,089 - $607,149	-11,300 Reduced 0.36%	3,089,158 $166 Million
Q3 2017 Oct 11, 2017	BUY	$41.15 - $49.22 $128 Million - $153 Million	3,100,458	3,100,458 $149 Million

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Novo Nordisk A S Transaction History